- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, August 11, 2023
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article in Forbes referenced a study published in the December 2020 issue of The American Journal of Managed Care® (AJMC®). The study, “Estimating the Economic Burden of Migraine on US Employers,” described the Migraine Impact Model and how it could estimate the prevalence of migraines in the workforce and the economic burden of those migraines on employers.
An article from GeneOnline referenced an article published AJMC’s sister site, The Center for Biosimilars®. The article, “Samsung Bioepis Report Correlates Biosimilar Pricing Changes With Market Adoption,” summarized the first edition of the Samsung Bioepis Biosimilar Market Report, which outlines the current state of the biosimilars market in the United States and how the increasing adoption of biosimilars has affected pricing changes for the medications and their reference products.
The Breakdown: Breast Cancer Research Awareness Day
August 19th 2025Breast cancer is the second most common cancer among women and the second leading cause of cancer-related deaths among women in the US. In light of Breast Cancer Research Awareness Day, The American Journal of Managed Care® breaks down the most recent advancements in breast cancer prevention, screening, and therapies.
Listen
Oral GC Dose Tapering for MG Linked to Efgartigimod Initiation
August 25th 2025Using US claims data, the authors evaluated oral glucocorticoid (GC) use at 5 time points during their retrospective analysis: 3 months before starting efgartigimod and 3, 6, 9, and 12 months after starting efgartigimod.
Read More
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
